Abstract
This observational study investigated intraoperative electrophysiological changes and their correlation with postoperative facial expressions in parotidectomy patients with visual confirmation of facial nerve (FN) continuity. Maximal electromyography(EMG) amplitudes of the facial muscles corresponding to temporal, zygomatic, buccal and mandibular branches were compared before/after FN dissection, and facial function at four facial regions were evaluated before/after parotidectomy in 112 patients. Comparisons of 448 pairs of EMG signals revealed at least one signal decrease after FN dissection in 75 (67%) patients. Regional facial weakness was only found in 13 of 16 signals with >50% amplitude decreases. All facial dysfunctions completely recovered within 6 months. EMG amplitude decreases often occur after FN dissection. An amplitude decrease >50% in an FN branch is associated with a high incidence of dysfunction in the corresponding facial region. This study tries to establish a standard facial nerve monitoring (FNM) procedure and a proper facial function grading system for parotid surgery that will be useful for the future study of FNM in parotid surgery.
Keywords: parotidectomy, facial nerve monitoring (FNM), electromyography (EMG), facial expression, facial grading system
1. Introduction
Facial dysfunction caused by facial nerve (FN) injury is a common and serious complication after surgery for parotid tumors. The reported incidence of facial dysfunction ranges from 14 to 66% for temporary facial weakness and from 0 to 9% for permanent facial weakness [1,2,3,4,5,6,7,8,9,10,11,12,13]. FN injury can cause facial asymmetry, mastication difficulty, drooling, and corneal ulceration. These dysfunctions have severe impacts on the patients’ quality of life and might lead to medical legal litigation.
To preserve FN function, identifying the main trunk of the FN and meticulously dissecting the FN branches are standard procedures in parotid surgery. However, unrecognized nerve injury during FN dissection and unexpected postoperative facial dysfunction or weakness can occur even when anatomical integrity of FN continuity is confirmed intraoperatively.
In recent decades, facial nerve monitoring (FNM) has been popularly applied as an adjunct during parotidectomy for: (i) early identification of the FN trunk; (ii) differentiation of the FN from other tissue and facilitation of FN branch dissection; (iii) confirmation of the functional integrity of the FN; (iv) detection of nerve injury and (v) prognostication of facial expression after resection of the parotid tumor [14,15,16,17,18,19,20,21,22,23,24,25]. However, due to lack of standard procedures for using FNM in parotidectomy, and lack of a proper system for grading facial function after parotidectomy, the value of FNM technology has been debated in the literature. Several studies have reported that use of FNM does not significantly reduce the incidences of temporary and permanent facial dysfunction [14,15,16,17]. Others have reported that FNM decreases the risk of temporary facial weakness but not the risk of permanent facial weakness [18,19,20]. Sajisevi et al. reported that patients who received revised parotidectomy with FNM had shorter operative time, less FN injury severity, and faster FN injury recovery compared with those without FNM [20]. Chiesa-Estomba et al. reported that FNM may decrease the risk of immediate postoperative and permanent FN injury in primary parotidectomy [21]. Ozturk et al. reported that no electrophysiologic parameters were reliable to predict FN dysfunction after superficial partial parotidectomy [22]. Meier et al. also reported that no abnormalities observed by intraoperative continuous FNM during parotidectomy were predictors of FN injury [23]. Nevertheless, Mamelle [24] and Guntinas-Lichius [25] reported that a low ratio of post-dissection to pre-dissection maximal response amplitude was associated with early postoperative facial dysfunction.
In this observational study, we focused on the change of EMG amplitude after FN dissection in patients with intraoperative visual integrity of FN. The EMG amplitudes of four elicited signals represent the function of each FN branch and regional area of facial muscles. When EMG amplitude decreases on one channel, it means that FN branch could be injured. We can map the position of amplitude decrease on the FN branch and detect nerve injury area using a stimulating probe. With this method, we can recognize if nerve injury is on the FN branch or main trunk. The amount of amplitude decrease may predict the regional facial expression after parotidectomy. All surgeries in our study were performed using the same standard procedure for FNM. The electromyography (EMG) amplitudes at four separate regions of facial muscle groups innervated by the temporal, zygomatic, buccal, and marginal mandibular branches of the FN were monitored before and after FN dissection. Additionally, facial function or expression was evaluated by examining individual dynamic movement of muscle groups over four facial regions. This study not only aims to investigate intraoperative changes in EMG amplitude after FN dissection and their correlations with postoperative facial function in patients with visual confirmation of anatomical integrity of FN branches, but also tries to establish a standard FNM procedure and a novel facial grading system for parotid surgery that will be useful for the future study of FNM.
2. Materials and Methods
This observational study retrospectively reviewed 120 patients who had undergone primary parotid surgery with FNM from January 2014 to December 2019. Pediatric patients, revision parotidectomy, or patients with bilateral parotid tumors were excluded before patient enrollment. All surgeries were performed by a single surgeon (F-Y, C). Eight parotid cancer patients were excluded due to preoperative facial paralysis or sacrifice of an FN branch during surgery. Thus, this study analyzed 105 benign and seven malignant tumors in 112 patients (51 females and 61 males; mean age, 49.7 ± 13.9 years) with intraoperative visual integrity of FN branches in continuity (Table 1).
Table 1.
Characteristics of Patients | 112 Patients (448 NBAR) |
---|---|
Pathologic reports | |
Benign | 105 patients |
Malignant | 7 patients |
Sex | |
Female | 51 patients |
Male | 61 patients |
Age (Mean ± SD) | 49.7 ± 13.9 years |
Surgical extent | |
Superficial parotidectomy | 89 patients |
Superficial and deep parotidectomy | 23 patients |
Transection facial nerve injury | 0 NBAR |
Mean EMG amplitude (F2/F1 signals) | |
Channel 1 | 983 ± 545/986 ± 592 µV |
Channel 2 | 1289 ± 905/1264 ± 940 µV |
Channel 3 | 1395 ± 961/1462 ± 922 µV |
Channel 4 | 1542 ± 907/1680 ± 986 µV |
Comparisons of F2 and F1 signal amplitudes | |
Unchanged | 223 (50%) NBAR |
Increased | 105 (23%) NBAR |
Decreased | 120 (27%) NBAR |
Abnormal regional facial function | |
Unchanged/Increased signal amplitude | 0 of 328 (0.0%) NBAR |
Decreased signal amplitude | |
<50% signal amplitude decrease | 0 of 104 (0.0%) NBAR |
>50% signal amplitude decrease | 13 of 16 (81.3%) NBAR |
SD = standard deviation; NBAR = Nerve branches at risk; EMG = electromyography.
All patients were informed of the intent to use FNM to help identify FN trunk and branches and to evaluate FN function during surgery. The authors had no personal, professional, or financial associations with the manufacturer of the nerve-monitoring device used in this study. Ethical approval of this study was obtained from the Kaohsiung Medical University Hospital Institutional Review Board (KMUHIRB-E(I)-20200136). The percentage, mean value, and standard deviations were calculated using Microsoft Excel 2016 (Microsoft Corp., Redmond, WA, USA).
2.1. General Anesthesia and Facial Nerve Monitoring Setup
Standard procedures for general anesthesia were performed by the intraoperative neuromonitoring team, which included two experienced anesthesiologists and one nurse anesthetist for anesthetic care and recording. After general anesthesia was induced with lidocaine (1 mg/kg), propofol (2–3 mg/kg); a single dose (0.3 mg/kg) of rocuronium was administered to facilitate endotracheal tube insertion. When maximal neuromuscular blockade was achieved, another bolus of propofol (50 mg) was given. Anesthesia was maintained with sevoflurane and propofol target-controlled infusion. No neuromuscular blocking agents (NMBA) were administered repeatedly during surgery.
After general anesthesia, intraoperative four-channel facial nerve EMG monitoring was performed with a NIM-Response 3.0 system (Medtronic Xomed, Jacksonville, FL, USA) in all patients. Four paired subdermal electrodes (length, 12.0 mm; diameter, 0.4 mm; Medtronic, Jacksonville, FL, USA) were inserted into the lower forehead, infraorbital area, superolateral upper lip and inferolateral lower lip on the ipsilateral side of surgery to monitor activity of facial muscles (Figure 1) innervated by the temporal, zygomatic, buccal, and marginal mandibular branches of the FN. After stimulation of the FN trunk, the elicited EMG signals were displayed on channels 1, 2, 3 and 4 of the monitor screen. The duration of stimulation was 100 µs, the event threshold was 100 µV, event capture was at the largest signal, stimulus current was 3 mA, and frequency was 4 Hz.
2.2. Evaluation of FN Function before and after FN Branch Dissection
During surgery, the main trunk of the FN was routinely stimulated with 3 mA when it was first identified. The EMG amplitudes of four elicited signals were used as reference values for FN function and defined as F1 signals (Figure 2A,B). The FN branches were then carefully dissected. After dissection of the FN branches and resection of the parotid tumor, the same stimulus current was applied to the FN trunk, and the elicited EMG signals were defined as F2 signals (Figure 2C,D). As the EMG amplitudes on each channel of F2 and F1 signals were compared, they could be classified as unchanged, increased or decreased. An unchanged amplitude was defined as an amplitude with a ±10% change; an increased amplitude was defined as an amplitude increase >10%; a decreased amplitude was defined as an amplitude decrease >10%. All FNs were also photographed after exposure (Table 2).
Table 2.
Procedures | Remarks |
---|---|
Grading facial function and photographing the four facial expressions before surgery | Evaluate dynamic movement of individual muscle groups over four separate facial regions by performing four rapid facial expressions |
General anesthesia and facial nerve monitoring setup | Only a single dose (0.3 mg/kg) of rocuronium is administered during induction of general anesthesia. Four paired subdermal electrodes are inserted into four separate regions to monitor activity of facial muscles innervated by the temporal, zygomatic, buccal, and marginal mandibular branches of FN. |
Pre-dissection EMG (F1 signals) | FN trunk is stimulated with 3 mA when it is first identified |
Post-dissection EMG (F2 signals) | After dissection of the FN branches, 3 mA is applied to FN trunk |
Interpretation of EMG signals (F2/F1 ratio) | Unchanged amplitude- amplitude change within ±10% Increased amplitude- amplitude increase >10% Decreased amplitude- amplitude decrease >10% |
Photographing the exposed FN branches | Confirmation of visual integrity of the FN |
Grading facial function and photographing the four facial expressions after surgery | If asymmetric facial expression is detected, compare with preoperative recording |
2.3. Assessment of Facial Function
Facial function or expression was assessed by at least two observers before surgery and one day after surgery. Our facial grading system evaluated dynamic movement of individual muscle groups over four separate facial regions (forehead, peri-orbital area, upper mouth, and lower mouth respectively controlled by the temporal, zygomatic, buccal and marginal mandibular branches of the FN). All patients were asked to perform four facial expressions rapidly: wrinkling the forehead, closing the eyes tightly, whistling, and smiling widely. The four facial expressions were photographed before and after surgery (Figure 3). Each of the four facial regions was scored from 3 to 0 points for each facial region according to the different grades of facial expressions. Normal facial function (3 points) was defined as a full symmetric dynamic movement of a facial region. Mild facial dysfunction (2 points) was defined as slightly asymmetrical dynamic movement but symmetrical facial expression. Moderate facial dysfunction (1 point) was defined as obvious asymmetrical dynamic movement and asymmetrical facial expression. Severe facial dysfunction (0 points) was defined as a complete lack of dynamic movement (Table 3). For example, a patient with normal function in each of the four branches would receive a total score 12, T(3)Z(3)B(3)M(3). All the patients with facial dysfunction received postoperative follow-up per month to evaluate the recovery of facial expression.
Table 3.
Degree | Description | Points |
---|---|---|
Normal function | A full symmetric dynamic movement of a facial region | 3 |
Mild dysfunction | A slightly asymmetrical dynamic movement but symmetrical facial expression | 2 |
Moderate dysfunction | An obvious asymmetrical dynamic movement and asymmetrical facial expression | 1 |
Severe dysfunction | A complete lack of dynamic movement | 0 |
3. Results
The analysis included 448 pairs of EMG signals obtained from the 112 patients in this study. The mean EMG amplitudes of F2/F1 signals were 983 ± 545/986 ± 592 µV on channel 1, 1289 ± 905/1264 ± 940 µV on channel 2, 1395 ± 961/1462 ± 922 µV on channel 3, and 1542 ± 907/1680 ± 986 µV on channel 4. Comparisons of F2 and F1 signal amplitudes on each channel showed unchanged amplitude in 223 (50%) signals, increased amplitude in 105 (23%) signals, and decreased amplitude in 120 (27%) signals. Regional facial function was normal in all 328 signals with unchanged or increased amplitudes (Table 1).
The 120 decreased amplitude signals were acquired from 75 patients (67%). Of these 75 patients, 41 patients had 1 decreased signal, 24 patients had 2 decreased signals, 9 patients had 3 decreased signals, and 1 patient had 4 decreased signals. The 120 decreased amplitude signals included 24 in the temporal branch, 19 in the zygomatic branch, 34 in the buccal branch and 43 in the marginal mandibular branch. Amplitude decreases were 10–20% in 42 signals, 20–30% in 32 signals, 30–40% in 23 signals, 40–50% in 7 signals, 50–60% in 2 signals, 60–70% in 7 signals, 70-80% in 4 signals and 80–90% in 3 signals. Regional facial weakness only occurred in 13 of the 16 signals in which amplitude decreases exceeded 50%. Of the thirteen patients with regional facial weakness, seven had mild facial dysfunction, and six had moderate facial dysfunction. The site of regional facial weakness in these thirteen patients was the peri-orbital area in one, the upper mouth in four, and the lower mouth in eight (Table 4). All facial dysfunctions completely recovered within 6 months.
Table 4.
Case Number | Age, Sex Side |
Branches of Facial Nerve | Amplitude Decrease (%) | Grade of Facial Dysfunction | Pathologic Report |
---|---|---|---|---|---|
Case 1 | 74, M Left |
Zygomatic | 85% | Normal | Warthin’s tumor |
Case 2 | 42, F Left |
Zygomatic Buccal |
75% 53% |
Mild Mild |
Pleomorphic adenoma |
Case 3 | 58, M Right |
Buccal | 66% | Mild | Pleomorphic adenoma |
Case 4 | 47, M Right |
Temporal | 53% | Normal | Pleomorphic adenoma |
Case 5 | 47, F Left |
Buccal, Mandibular |
75% 61% |
Mild Moderate |
Warthin’s tumor |
Case 6 | 70, F Right |
Mandibular | 69% | Mild | Lymphoepithelial cyst |
Case 7 | 67, M Left |
Mandibular | 68% | Moderate | Warthin’s tumor |
Case 8 | 55, M Right |
Zygomatic | 70% | Normal | Hemangioma |
Case 9 | 39, F Right |
Buccal Mandibular |
62% 73% |
Mild Moderate |
Myoepithelioma |
Case 10 | 53, M Left |
Mandibular | 63% | Mild | Warthin’s tumor |
Case 11 | 38, F Right |
Mandibular | 61% | Moderate | Oncocytoma |
Case 12 | 48, M Left |
Mandibular | 82% | Moderate | Salivary duct carcinoma |
Case 13 | 54, M Right |
Mandibular | 90% | Moderate | Warthin’s tumor |
4. Discussion
The facial muscles are a group of striated skeletal muscles innervated by the FN that controls facial expression. When FNM is applied in parotid surgery, EMG is used as a diagnostic technique to assess the function of facial muscles and the corresponding FN branches that innervate them. The EMG amplitude is the sum of all differences in the electric potential of all active motor units of a muscle. Measurements of EMG amplitude may correlate with the number of motor units that contribute to polarization [26,27]. Theoretically, an unchanged or increased EMG amplitude after FN branch dissection indicates that postoperative FN function and facial expression will be normal. In this study, all of the 328 signals with unchanged or increased amplitudes showed normal regional facial function after surgery. Conversely, decreased EMG amplitude after FN dissection indicates a nerve function deficit or a decreased number of motor units participating in polarization. However, the correlation between the residual ratio of EMG amplitude after FN injury and the sufficient muscle strength required for normal facial expression is still unknown. In our series, we found the occurrence of EMG amplitude decreases was common after FN branch dissection. In 112 patients with integral continuity of FN branches, 75 patients (67%) had at least one decreased signal after FN dissection. Although 120 signals were detected with decreased amplitude, only 13 of the 16 signals that had an amplitude decrease >50% showed regional facial weakness. These results suggest that patients with a high ratio of amplitude decreases may not have sufficient facial muscle strength for symmetrical facial expression. Mamelle et al. [25] also reported that a low postdissection to predissection ratio of maximal response amplitude was associated with early postoperative facial dysfunction.
The mechanism of FN injury during parotidectomy may include nerve transection, traction, mechanical dissection trauma, ligature entrapment, thermal injury and ischemia. [3] All FN branches in our study were meticulously dissected after identification of the FN trunk. We found mechanical dissection trauma and traction injury were the most important factors for FN injury in patients with ensured anatomical continuity of FN branches. Most mechanical dissection traumas or traction injuries cannot be visually detected. However, in some cases, e.g., parotid cancer with extracapsular extension (Figure 4) or deep lobe tumor (Figure 5), in which FN branches are adhered to the tumor, a nerve branch segment may appear red and swollen after nerve dissection. The severity of nerve injury can be evaluated by comparing EMG amplitudes between F2 and F1 signals on each channel. A notable finding of this study is that some patients with decreased EMG amplitude after FN dissection had partial or complete intraoperative recovery of EMG. Intraoperative recovery of EMG in these patients was very similar to thyroid surgery patients with traction injury of the recurrent laryngeal nerve (RLN) that showed gradual and progressive recovery of EMG amplitude [28,29,30]. This finding may explain why two patients with substantial amplitude decreases (70% and 85%) still had normal facial expression after surgery. The knowledge of RLN IONM includes the standardization procedure [31], the mechanism of RLN injury [30], and the correlation between electrophysiological change of RLN and vocal cord function [32,33] are helpful for the development of FNM technique. The current study was focused on FNM in parotid surgery. We tried to establish a standard FNM procedure, which may have contribution to the research of FNM such as IONM of RLN in the future, such as (1) to detect where the FN was injured, (2) to elucidate the mechanism of FN injury, (3) to predict the outcome of postoperative facial function, (4) to differentiate a reversible from irreversible FN injury.
The various systems for grading FN function that have been discussed in the literature can be classified as global and regional, or as subjective and objective [34,35,36,37,38,39,40]. The House-Brackmann and Sunnybrook facial grading systems are most used to evaluate facial function. However, the House-Brackmann grading system measures the global function of the facial nerve, which is most applicable in lesions or injuries to the trunk of the facial nerve and not suitable for parotidectomy patients. The Sunnybrook facial grading system evaluates six facial movements (eyebrows, eyelids, nasal base, upper lip, and lower lip). Furthermore, the system globally evaluates resting symmetry, symmetry of voluntary movement, and the degree of synkinesis, which are too complex to execute after parotidectomy. A uniform system for grading facial function after parotidectomy has not been established. Stodulski et al. emphasized that an adequate assessment of FN function after parotidectomy requires a careful assessment of functional deficits in individual FN branches. Ideally, a scale for FN function should be highly reproducible, be quick and easy to perform, and account for the severity of damage to individual FN branches [39]. The current study assessed facial function by examining dynamic movement of individual muscle groups at the four facial regions innervated by temporal, zygomatic, buccal and marginal mandibular branches of the FN. In all patients, four rapid facial expressions were evaluated by at least two observers and photographed before and after surgery. In the 10 patients with facial dysfunction, seven had facial weakness in one region, and three had facial weakness in two regions. The seven patients with slight asymmetry in dynamic movement had mild facial dysfunction. Six patients had moderate facial dysfunction. In all six patients, dysfunction was at the lower mouth area (Table 4). No facial dysfunctions were classified as severe, and all facial dysfunctions completely recovered within 6 months. Based on the results of this study, we conclude that this facial grading system is a simple, quick, reliable and reproducible method of evaluating facial function after parotidectomy.
When FNM is used in parotid surgery, NMBA should be avoided because a neuromuscular blockade will interfere with the interpretation of intraoperative EMG amplitudes [3,19]. However, the absence of adequate neuromuscular blockade during endotracheal intubation increases the risk of laryngeal trauma and the difficulty of intubation [41]. Lu et al. reported that reversal of rocuronium (sugammadex) provides adequate neuromuscular blockade during induction of general anesthesia and does not interfere with interpretation of EMG amplitudes during FNM [42]. However, the high cost of sugammadex limits its routine use in FNM. Lu et al. also reported that the correlated twitch of neuromuscular transmission showed around 73% of recovery at 30 min after administration of 1 ED95 of rocuronium (0.3 mg/kg) during intraoperative neuromonitoring of RLN in thyroid surgery, and high EMG signals were obtained in all patients at an early stage of surgery [43]. To ensure safe endotracheal intubation in our study, a low dose (0.3 mg/kg) of rocuronium was administered at induction of general anesthesia, and satisfactory intubation was achieved in most patients. The time from induction of general anesthesia to the first FN trunk stimulation approximated to 60 min. Comparison of F2 and F1 signals showed that 50% were unchanged, 23% were increased, and 27% were decreased. This result suggested that low-dose rocuronium had a minimal effect on the reference F1 signal.
Several limitations of this study are noted:
-
(1)
The lack of a control group, good statistical analysis, detailed data regarding type of parotidectomy, tumor size, tumor location and extent of parotid resection and FN dissection were the major shortcoming of this study. However, this study was focused on the change of EMG amplitude and the risk of facial dysfunction after facial nerve dissection with our standard FNM procedure and facial function grading system. Our results showed that regional facial weakness occurred in 13 of 16 signals (81%) with >50% amplitude decrease. An amplitude decrease >50% in an FN branch is associated with a high incidence of dysfunction in the corresponding facial region.
-
(2)
Defining an unchanged amplitude after FN dissection is difficult. On each channel, some difference of EMG amplitude was observed between two consecutive stimulations. Therefore, an EMG amplitude change of ±10% may be interpreted as a normal variation of the monitoring system.
-
(3)
This study focused on cases with integral continuity of FN branches after parotid tumor resection. Future studies should investigate the outcomes after intraoperative transection of FN branch.
-
(4)
The cases with large amplitude decrease were limited, although the results showed a high incidence of facial dysfunction in the signals with amplitude decrease >50%. Further study with large volume in multiple centers is necessary.
5. Conclusions
Lack of a standard FNM procedure and uniform facial grading system for parotidectomy has limited the value of FNM in parotid surgery. The standardized FNM procedure and facial grading system used in this observational study are useful not only for identification of the FN trunk and branches, but also for intraoperative assessment of FN function after resection of a tumor, for detection of nerve injury, and for elucidation of an injury mechanism. Therefore, surgeons may use the procedure and grading system applied in this study to assess improvements in surgical technique and to predict facial function outcomes after surgery. Although an EMG amplitude decrease is common after FN dissection in parotid surgery, regional weakness of facial expression rarely occurred in patients with an amplitude decrease < 50% in the corresponding FN branch. However, patients with an amplitude decrease > 50% had a high incidence of facial dysfunction.
Acknowledgments
The authors gratefully acknowledge the technical assistance provided by Hui-Chun Chen (clinical nurse specialist, Department of Nursing, KMUH).
Author Contributions
Supervision—F.-Y.C., C.-W.W., T.-Z.H.; materials—F.-Y.C., T.-Y.H., T.-Z.H.; data collection and processing—C.-C.W. (Chih-Chun Wang), C.-F.L., C.-C.W. (Chien-Chung Wang), T.-Y.H.; analysis and interpretation—C.-C.W. (Chih-Chun Wang), I.-C.L., P.-Y.C., Y.-C.L., T.-Z.H.; literature Search—F.-Y.C., C.-W.W., I.-C.L., P.-Y.C., T.-Y.H.; writing manuscript—All authors. All authors have read and agreed to the published version of the manuscript.
Funding
This study was supported by grants from Kaohsiung Medical University Hospital, Kaohsiung Medical University (KMUH108-8M48, KMUH109-9M44), Kaohsiung Municipal Siaogang Hospital/Kaohsiung Medical University Research Center grants (KMHK-DK(C)110009, I-109-04, H-109-05, I-108-02), and Ministry of Science and Technology (MOST 108-2628-B-037-006, MOST 109-2628-B-037-014, MOST 110-2314-B-037-104-MY2, MOST 110-2314-B-037-120), Taiwan.
Institutional Review Board Statement
The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Kaohsiung Medical University Hospital Institutional Review Board (KMUHIRB-E(I)-20200136).
Informed Consent Statement
Patient consent was waived. The study had minimal risks and the potential risk level to the study subjects was not beyond the level of nonparticipants. In addition, the rights of the study subjects were not affected.
Data Availability Statement
The original contributions presented in the study are included in the article. Further inquiries can be directed to the corresponding authors.
Conflicts of Interest
The authors declare no conflict of interest.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.O’Brien C.J. Current management of benign parotid tumors—The role of limited superficial parotidectomy. Head Neck. 2003;25:946–952. doi: 10.1002/hed.10312. [DOI] [PubMed] [Google Scholar]
- 2.Terrell J.E., Kileny P.R., Yian C., Esclamado R.M., Bradford C.R., Pillsbury M.S., Wolf G.T. Clinical outcome of continuous facial nerve monitoring during primary parotidectomy. Arch. Otolaryngol.—Head Neck Surg. 1997;123:1081–1087. doi: 10.1001/archotol.1997.01900100055008. [DOI] [PubMed] [Google Scholar]
- 3.Eisele D.W., Wang S.J., Orloff L.A. Electrophysiologic facial nerve monitoring during parotidectomy. Head Neck. 2010;32:399–405. doi: 10.1002/hed.21190. [DOI] [PubMed] [Google Scholar]
- 4.Dulguerov P., Marchal F., Lehmann W. Postparotidectomy facial nerve paralysis: Possible etiologic factors and results with routine facial nerve monitoring. Laryngoscope. 1999;109:754–762. doi: 10.1097/00005537-199905000-00014. [DOI] [PubMed] [Google Scholar]
- 5.Guntinas-Lichius O., Gabriel B., Peter Klussmann J. Risk of facial palsy and severe Frey’s syndrome after conservative parotidectomy for benign disease: Analysis of 610 operations. Acta Oto-Laryngol. 2006;126:1104–1109. doi: 10.1080/00016480600672618. [DOI] [PubMed] [Google Scholar]
- 6.Mehle M.E., Kraus D.H., Wood B.G., Benninger M.S., Eliachar I., Levine H.L., Tucker H.M., Lavertu P. Facial nerve morbidity following parotid surgery for benign disease: The Cleveland Clinic Foundation experience. Laryngoscope. 1993;103:386–388. doi: 10.1002/lary.5541030404. [DOI] [PubMed] [Google Scholar]
- 7.Bron L.P., O’Brien C.J. Facial nerve function after parotidectomy. Arch. Otolaryngol.—Head Neck Surg. 1997;123:1091–1096. doi: 10.1001/archotol.1997.01900100065009. [DOI] [PubMed] [Google Scholar]
- 8.Witt R.L. Facial nerve function after partial superficial parotidectomy: An 11-year review (1987–1997) Otolaryngol. Head Neck Surg. 1999;121:210–213. doi: 10.1016/S0194-5998(99)70173-7. [DOI] [PubMed] [Google Scholar]
- 9.Mra Z., Komisar A., Blaugrund S.M. Functional facial nerve weakness after surgery for benign parotid tumors: A multivariate statistical analysis. Head Neck. 1993;15:147–152. doi: 10.1002/hed.2880150210. [DOI] [PubMed] [Google Scholar]
- 10.Anjum K., Revington P., Irvine G. Superficial parotidectomy: Antegrade compared with modified retrograde dissections of the facial nerve. Br. J. Oral Maxillofac. Surg. 2008;46:433–434. doi: 10.1016/j.bjoms.2008.03.018. [DOI] [PubMed] [Google Scholar]
- 11.Laccourreye H., Laccourreye O., Cauchois R., Jouffre V., Ménard M., Brasnu D. Total conservative parotidectomy for primary benign pleomorphic adenoma of the parotid gland: A 25-year experience with 229 patients. Laryngoscope. 1994;104:1487–1494. doi: 10.1288/00005537-199412000-00011. [DOI] [PubMed] [Google Scholar]
- 12.Jin H., Kim B.Y., Kim H., Lee E., Park W., Choi S., Chung M.K., Son Y.-I., Baek C.-H., Jeong H.-S. Incidence of postoperative facial weakness in parotid tumor surgery: A tumor subsite analysis of 794 parotidectomies. BMC Surg. 2019;19:199. doi: 10.1186/s12893-019-0666-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.O’Regan B., Bharadwaj G., Bhopal S., Cook V. Facial nerve morbidity after retrograde nerve dissection in parotid surgery for benign disease: A 10-year prospective observational study of 136 cases. Br. J. Oral Maxillofac. Surg. 2007;45:101–107. doi: 10.1016/j.bjoms.2006.03.009. [DOI] [PubMed] [Google Scholar]
- 14.Graciano A.J., Fischer C.A., Coelho G.V., Steck J.H., Paschoal J.R., Chone C.T. Facial nerve dysfunction after superficial parotidectomy with or without continuous intraoperative electromyographic neuromonitoring: A prospective randomized pilot study. Eur. Arch. Oto-Rhino-Laryngol. 2018;275:2861–2868. doi: 10.1007/s00405-018-5130-1. [DOI] [PubMed] [Google Scholar]
- 15.Ballivet-de Régloix S., Grinholtz-Haddad J., Maurin O., Genestier L., Lisan Q., Pons Y. Facial nerve monitoring during parotidectomy: A two-center retrospective study. Iran. J. Otorhinolaryngol. 2016;28:255. [PMC free article] [PubMed] [Google Scholar]
- 16.Grosheva M., Klussmann J.P., Grimminger C., Wittekindt C., Beutner D., Pantel M., Volk G.F., Guntinas-Lichius O. Electromyographic facial nerve monitoring during parotidectomy for benign lesions does not improve the outcome of postoperative facial nerve function: A prospective two-center trial. Laryngoscope. 2009;119:2299–2305. doi: 10.1002/lary.20637. [DOI] [PubMed] [Google Scholar]
- 17.Witt R.L. Facial nerve monitoring in parotid surgery: The standard of care? Otolaryngol.—Head Neck Surg. 1998;119:468–470. doi: 10.1016/S0194-5998(98)70103-2. [DOI] [PubMed] [Google Scholar]
- 18.Savvas E., Hillmann S., Weiss D., Koopmann M., Rudack C., Alberty J. Association between facial nerve monitoring with postoperative facial paralysis in parotidectomy. JAMA Otolaryngol.—Head Neck Surg. 2016;142:828–833. doi: 10.1001/jamaoto.2016.1192. [DOI] [PubMed] [Google Scholar]
- 19.Sood A.J., Houlton J.J., Nguyen S.A., Gillespie M.B. Facial nerve monitoring during parotidectomy: A systematic review and meta-analysis. Otolaryngol.—Head Neck Surg. 2015;152:631–637. doi: 10.1177/0194599814568779. [DOI] [PubMed] [Google Scholar]
- 20.Ozturk K., Akyildiz S., Gode S., Turhal G., Gursan G., Kirazli T. The effect of partial superficial parotidectomy on amplitude, latency and threshold of facial nerve stimulation. Arch. Oto-Rhino-Laryngol. 2016;273:1527–1531. doi: 10.1007/s00405-015-3622-9. [DOI] [PubMed] [Google Scholar]
- 21.Sajisevi M. Indications for Facial Nerve Monitoring During Parotidectomy. Otolaryngol. Clin. N. Am. 2021;54:489–496. doi: 10.1016/j.otc.2021.02.001. [DOI] [PubMed] [Google Scholar]
- 22.Chiesa-Estomba C.M., Larruscain-Sarasola E., Lechien J.R., Mouawad F., Calvo-Henriquez C., Diom E.S., Ramirez A., Ayad T. Facial nerve monitoring during parotid gland surgery: A systematic review and meta-analysis. Arch. Oto-Rhino-Laryngol. 2021;278:933–943. doi: 10.1007/s00405-020-06188-0. [DOI] [PubMed] [Google Scholar]
- 23.Meier J.D., Wenig B.L., Manders E.C., Nenonene E.K. Continuous intraoperative facial nerve monitoring in predicting postoperative injury during parotidectomy. Laryngoscope. 2006;116:1569–1572. doi: 10.1097/01.mlg.0000231266.84401.55. [DOI] [PubMed] [Google Scholar]
- 24.Guntinas-Lichius O., Eisele D.W. Salivary Gland Neoplasms. Volume 78. Karger Publishers; Basel, Switzerland: 2016. Facial nerve monitoring; pp. 46–52. [DOI] [PubMed] [Google Scholar]
- 25.Mamelle E., Bernat I., Pichon S., Granger B., Sain-Oulhen C., Lamas G., Tankéré F. Supramaximal stimulation during intraoperative facial nerve monitoring as a simple parameter to predict early functional outcome after parotidectomy. Acta Oto-Laryngol. 2013;133:779–784. doi: 10.3109/00016489.2013.771283. [DOI] [PubMed] [Google Scholar]
- 26.Behm D., Whittle J., Button D., Power K. Intermuscle differences in activation. Muscle Nerve. 2002;25:236–243. doi: 10.1002/mus.10008. [DOI] [PubMed] [Google Scholar]
- 27.Roberts T.J., Gabaldón A.M. Interpreting muscle function from EMG: Lessons learned from direct measurements of muscle force. Integr. Comp. Biol. 2008;48:312–320. doi: 10.1093/icb/icn056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Liu M.-Y., Chang C.-P., Hung C.-L., Hung C.-J., Huang S.-M. Traction Injury of Recurrent Laryngeal Nerve during Thyroidectomy. World J. Surg. 2020;44:402–407. doi: 10.1007/s00268-019-05178-6. [DOI] [PubMed] [Google Scholar]
- 29.Wu C.-W., Dionigi G., Sun H., Liu X., Kim H.Y., Hsiao P.-J., Tsai K.-B., Chen H.-C., Chen H.-Y., Chang P.-Y. Intraoperative neuromonitoring for the early detection and prevention of RLN traction injury in thyroid surgery: A porcine model. Surgery. 2014;155:329–339. doi: 10.1016/j.surg.2013.08.015. [DOI] [PubMed] [Google Scholar]
- 30.Chiang F.-Y., Lu I.-C., Kuo W.-R., Lee K.-W., Chang N.-C., Wu C.-W. The mechanism of recurrent laryngeal nerve injury during thyroid surgery—The application of intraoperative neuromonitoring. Surgery. 2008;143:743–749. doi: 10.1016/j.surg.2008.02.006. [DOI] [PubMed] [Google Scholar]
- 31.Chiang F.-Y., Lee K.-W., Chen H.-C., Chen H.-Y., Lu I.-C., Kuo W.-R., Hsieh M.-C., Wu C.-W. Standardization of intraoperative neuromonitoring of recurrent laryngeal nerve in thyroid operation. World J. Surg. 2010;34:223–229. doi: 10.1007/s00268-009-0316-8. [DOI] [PubMed] [Google Scholar]
- 32.Yuan Q., Wu G., Hou J., Liao X., Liao Y., Chiang F.-Y. Correlation between electrophysiological changes and outcomes of vocal cord function in 1764 recurrent laryngeal nerves with visual integrity during thyroidectomy. Thyroid. 2020;30:739–745. doi: 10.1089/thy.2019.0361. [DOI] [PubMed] [Google Scholar]
- 33.Wu C.-W., Hao M., Tian M., Dionigi G., Tufano R.P., Kim H.Y., Jung K.Y., Liu X., Sun H., Lu I.-C. Recurrent laryngeal nerve injury with incomplete loss of electromyography signal during monitored thyroidectomy—Evaluation and outcome. Langenbeck’s Arch. Surg. 2017;402:691–699. doi: 10.1007/s00423-016-1381-8. [DOI] [PubMed] [Google Scholar]
- 34.House W. Facial nerve grading system. Otolaryngol. Head Neck Surg. 1985;93:184–193. doi: 10.1177/019459988509300202. [DOI] [PubMed] [Google Scholar]
- 35.Burres S., Fisch U. The comparison of facial grading systems. Arch. Otolaryngol.—Head Neck Surg. 1986;112:755–758. doi: 10.1001/archotol.1986.03780070067015. [DOI] [PubMed] [Google Scholar]
- 36.Murty G.E., Diver J.P., Kelly P.J., O’Donoghue G., Bradley P.J. The Nottingham System: Objective assessment of facial nerve function in the clinic. Otolaryngol.—Head Neck Surg. 1994;110:156–161. doi: 10.1177/019459989411000203. [DOI] [PubMed] [Google Scholar]
- 37.Croxson G., May M., Mester S.J. Grading facial nerve function: House-Brackmann versus Burres-Fisch methods. Am. J. Otol. 1990;11:240–246. [PubMed] [Google Scholar]
- 38.O’Reilly B.F., Soraghan J.J., McGrenary S., He S. Objective method of assessing and presenting the House-Brackmann and regional grades of facial palsy by production of a facogram. Otol. Neurotol. 2010;31:486–491. doi: 10.1097/MAO.0b013e3181c993dc. [DOI] [PubMed] [Google Scholar]
- 39.Stodulski D., Skorek A., Mikaszewski B., Wiśniewski P., Stankiewicz C. Facial nerve grading after parotidectomy. Arch. Oto-Rhino-Laryngol. 2015;272:2445–2450. doi: 10.1007/s00405-014-3196-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Ross B.G., Fradet G., Nedzelski J.M. Development of a sensitive clinical facial grading system. Otolaryngol.—Head Neck Surg. 1996;114:380–386. doi: 10.1016/S0194-5998(96)70206-1. [DOI] [PubMed] [Google Scholar]
- 41.Mencke T., Echternach M., Kleinschmidt S., Lux P., Barth V., Plinkert P.K., Fuchs-Buder T. Laryngeal morbidity and quality of tracheal intubationa randomized controlled trial. J. Am. Soc. Anesthesiol. 2003;98:1049–1056. doi: 10.1097/00000542-200305000-00005. [DOI] [PubMed] [Google Scholar]
- 42.Lu I.-C., Chang P.-Y., Su M.-P., Chen P.-N., Chen H.-Y., Chiang F.-Y., Wu C.-W. The feasibility of sugammadex for general anesthesia and facial nerve monitoring in patients undergoing parotid surgery. Kaohsiung J. Med Sci. 2017;33:400–404. doi: 10.1016/j.kjms.2017.06.002. [DOI] [PubMed] [Google Scholar]
- 43.Lu I.-C., Tsai C.-J., Wu C.-W., Cheng K.-I., Wang F.-Y., Tseng K.-Y., Chiang F.-Y. A comparative study between 1 and 2 effective doses of rocuronium for intraoperative neuromonitoring during thyroid surgery. Surgery. 2011;149:543–548. doi: 10.1016/j.surg.2010.11.006. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The original contributions presented in the study are included in the article. Further inquiries can be directed to the corresponding authors.